PPMD Community

[Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study

Event Details

[Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study

Time: October 25, 2017 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: http://www.parentprojectmd.or…
Event Type: webinar
Organized By: PPMD
Latest Activity: Oct 18

Export to Outlook or iCal (.ics)

Event Description

Please join Parent Project Muscular Dystrophy and FibroGen as we host a webinar Wednesday, October 25 at 1:00 PM EDT to hear a community update on FibroGen’s development of Pamrevlumab and currently enrolling FGCL-3019-079 non-ambulatory study in Duchenne muscular dystrophy.

 

Host:

  • Kathi Kinnett, MSN, CNP
    Senior Vice President, Clinical Care
    Parent Project Muscular Dystrophy

Speaker:

  • Elias Kouchakji, MD
    Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
    FibroGen


To Participate:

View call-in information & pre-register to receive a reminder email for this webinar.


Submit Questions:

Please submit questions in advance to info@parentprojectmd.org (subject line: FibroGen Webinar) by Monday, October 23rd at 12:00 PM ET.

Comment Wall

Comment

RSVP for [Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study to add comments!

Join PPMD Community

Attending (1)

© 2017   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service